Polycystin-1 C terminus cleavage and its relation with polycystin-2, two proteins involved in polycystic kidney disease;Clivaje del C-terminal de policistina-1 y su relación con policistina-2, dos proteínas involucra-das en la poliquistosis renal

Medicina (Argentina)

Volumn 73, Issue 2, 2013, Pages 155-162

  Bertuccio, Claudia A ^a   Caplan, Michael J ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C terminal tail (CTT) cleavage of polycystin 1; Ca2+; cAMP; mTOR; Polycystin 1 (PC 1); Polycystin 2 (PC 2); Primary cilium

Indexed keywords

CYCLIC AMP; JANUS KINASE 2; POLYCYSTIN 1; POLYCYSTIN 2; STAT1 PROTEIN; STAT3 PROTEIN; CALCIUM CHANNEL; CALCIUM ION; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN;

APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; IMMUNOCYTOCHEMISTRY; KIDNEY POLYCYSTIC DISEASE; LIPID METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RENAL REPLACEMENT THERAPY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; C-TERMINAL TAIL (CTT) CLEAVAGE OF POLYCYSTIN-1; CELL NUCLEUS; GENETICS; KIDNEY TUBULE; METABOLISM; MTOR; MUTATION; PHYSIOLOGY; POLYCYSTIN-1 (PC-1); POLYCYSTIN-2 (PC-2); PRIMARY CILIUM;

C-TERMINAL TAIL (CTT) CLEAVAGE OF POLYCYSTIN-1; CA2+; CAMP; MTOR; POLYCYSTIN-1 (PC-1); POLYCYSTIN-2 (PC-2); PRIMARY CILIUM;

ANIMALS; APOPTOSIS; CALCIUM CHANNELS; CELL NUCLEUS; CELL PROLIFERATION; CYCLIC AMP; HUMANS; KIDNEY TUBULES; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TRPP CATION CHANNELS;

EID: 84877886933     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332-42.
2. Burn TC, Connors TD, Dackowski WR, et al. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium). Hum Mol Genet 1995; 4: 575-82.
3. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-42.
4. Lal M, Caplan M. Regulated intramembrane proteolysis: signaling pathways and biological functions. Physiology (Bethesda) 2011; 26: 34-44.
5. Hughes J, Ward C, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995; 10: 151-60.
6. Sandford R, Sgotto B, Aparicio S, et al. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet 1997; 6: 1483-9.
7. Qian F, Boletta A, Bhunia AK, et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci USA 2002; 99: 16981-6.
8. Chauvet V, Tian X, Husson H, et al. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest 2004; 114: 1433-43.
9. Low SH, Vasanth S, Larson CH, et al. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 2006; 10: 57-69.
10. Talbot JJ, Shillingford JM, Vasanth S, et al. Polycystin-1 regulates STAT activity by a dual mechanism. Proc Natl Acad Sci USA 2011; 108: 7985-90.
11. Merrick D, Baggs JE, Yu Z, et al. The γ-secretase cleavage product of Polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism. Dev Cell 2012; 22: 197-210.
12. Parfrey PS, Bear JC, Morgan J, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. New Engl J Med 1990; 323: 1085-90.
13. Cai Y, Maeda Y, Cedzich A, et al. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 1999; 274: 28557-65.
14. Koulen P, Cai Y, Geng L, et al. Polycystin-2 is an intracellular calcium release channel. Cell Biol 2002; 4: 191-7.
15. Lu W, Zhou J. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997; 17: 179-81.
16. Wu G, D'Agati V, Cai Y, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998; 93:177-88.
17. Newby LJ, Streets AJ, Zhao Y, et al. Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex. J Biol Chem 2002; 277: 20763-73.
18. Hanaoka K, Qian F, Boletta A, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000; 408: 990-4.
19. Qian F, Germino FJ, Cai Y, et al. PKD1 interacts with PKD2 through a probable coiled-coil domain: Nat Genet 1997; 16: 179-83.
20. Tsiokas L, Kim E, Arnould T, et al. Homo and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 1997; 94: 6965-70.
21. 2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 2001; 98: 1182-7.
22. Xu GM, González-Perrett S, Essafi M, et al. Polycystin-1 activates and stabilizes the polycystin-2 channel. J Biol Chem 2003; 278: 1457-62.
23. Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003; 33: 129-37.
24. Nauli SM, Kawanabe Y, Kaminski J, et al. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 2008; 117, 1161-71.
25. Aboualaiwi W, Takahashi M, Mell B, et al. Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ Res 2009; 104, 860-9.
26. Praetorius HA, Spring KR. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 2001; 184: 71-9.
27. 2+ signaling. Am J Physiol Renal Physiol 2004; 287: F969-78.
28. Parnell SC, Magenheimer BS, Maser RL, et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Comm 1998; 251, 625-31.
29. Arnould T, Sellin L, Benzing T, et al. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol 1999; 19, 3423-34.
30. Bhunia AK, Piontek K, Boletta A, et al. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002; 109: 157-68.
31. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-57.
32. van Adelsberg J. Polycystin-1 interacts with E-cadherin and the catenins-clues to the pathogenesis of cyst formation in ADPKD? Nephrol Dial Transplant 2000; 15: 1-2.
33. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-84.
34. Tee AR, Blenis J. mTOR, translational control and human disease. Semin Cell Dev Biol 2005; 16: 29-37.
35. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412: 179-90.
36. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006; 355: 1345-56.
37. Brook-Carter PT, Peral B, Ward CJ, et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome. Nat Genet 1994; 8: 328-32.
38. Sampson JR, Maheshwar MM, Aspinwall R, et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997; 61: 843-51.
39. Kleymenova E, Ibraghimov-Beskrovnaya O, Kugoh H, et al. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol Cell 2001; 7: 823-32.
40. Shillingford JM, Murcia NS, Larson CH, et al. From the Cover: The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006; 103: 5466-71.
41. Wu MJ, Wen MC, Chiu YT, et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006; 69: 2029-36.
42. Lieberthal W, Fuhro R, Andry CC, et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001; 281: F693-706.
43. Dere R, Wilson PD, Sandford RN, et al. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One 2010; 5: e9239.
44. Sutters M, Yamaguchi T, Maser RL, et al. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int 2001; 60: 484-94.
45. Wallace DP, Grantham JJ, Sullivan LP. Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 1996; 50: 1327-36.
46. Hanaoka K, Devuyst O, Schwiebert EM, et al. A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 1996; 270: C389-99.
47. Sullivan LP, Wallace DP, Grantham JJ. Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 1998; 9: 903-16.
48. Yamaguchi T, Hempson SJ, Reif GA, et al. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 2006; 17: 178-87.
49. Yamaguchi T, Nagao S, Wallace DP, et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003; 63: 1983-94.
50. 2+ signaling. Am J Physiol Renal Physiol 2007; 292: F930-45.
51. Choia Y, Suzukia A, Hajarnisa S, et al. Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc Natl Acad Sci USA 2011; 108: 26, 10679-84.
52. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009; 10: 53-62.
53. Nauli SM, Jin X, Hierck BP. The mechanosensory role of primary cilia in vascular hypertension. Int J Vasc Med 2011; 376281. doi: 10.1155/2011/376281. Epub 2011 Jun 16.
54. Palsson R, Sharma CP, Kim K, et al. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med 1996; 2, 702-11.
55. Geng L, Segal Y, Peissel B, et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996; 98, 2674-82.
56. Griffin MD, Torres VE, Grande JP, Kumar R. Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Physicians 1996; 108, 185-97.
57. Bertuccio CA, Chapin HC, Cai Y, et al. Polycystin-1 C-terminal cleavage is modulated by polycystin-2 expression. J Biol Chem 2009; 284: 21011-26.
58. Serra AL, Poster D, Kistler AD, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363: 820-29.
59. Walz G, Budde K, Mannaa M, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2010; 363: 830-40.